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TO  STUDY  THE  IMMUNOHISTOCHEMICAL EXPRESSION OF 
BCL-2 IN ENDOMETRIAL CARCINOMA AND  ITS CORRELATION 
WITH HORMONE RECEPTOR  STATUS  AND TRANSFORMING 
GROWTH FACTOR. 
Abstract: 
Endometrial carcinoma is the most common malignant tumor of the 
female genital tract with increasing incidence in developed countries.  In the 
era of targeted therapy immunohistochemical markers plays an important role 
in the treatment and prognosis of endometrial carcinoma. 
Aims and objectives 
To  study the immunohistochemical expression of Bcl-2 in endometrial 
carcinoma. 
To study the correlation of Bcl-2 expression with hormone receptor 
status and transforming growth factor receptor in endometrial carcinoma. 
Methods: 
  59 cases of endometrial carcinoma reported between the period from 
January 2010 to December 2014  in  the department of pathology of this 
institute were considered in the study.  Immunohistochemical staining for Bcl-
2, ER, PR, Her 2/neu were done.Bcl-2 expression was correlated with ER, PR 
and Her 2/ neu receptor expression.Results 
Results: 
  Bcl-2 expression was  seen in 38 out of 59 cases ( 64.4%) . Bcl-2 was 
mostly expressed  in 85.71% of  grade I tumors and 75.75% of stage I tumors . 
Estrogen receptor was positive in 33 cases ( 55.9%) and Progesterone receptor 
was positive in 44 cases ( 74.57%) .Grade I tumors showed 71.4% and 94.28% 
positivity of estrogen and progesterone receptor respectively. ER, PR were 
positive in 63.3% and 84.8% of stage I tumors respectively. Both ER, PR  
negative in high grade , non- endometrioid and advanced stage of endometrial 
carcinomas .Her 2 neu receptor was positive in  6 cases       ( 10.1%)  , all four 
type II tumors were showed Her2/new expression. 100 % of grade III tumors ,  
80 % of stage III and all stage IV tumors were Her 2 neu receptor positive. 
Conclusion: 
   From our study we inferred estrogen , progesterone receptor  and Bcl-2 
were positive in grade I and stage I tumors . Bcl-2 expression is directly 
proportional to estrogen and progesterone receptors.  Her 2 neu receptors were 
expressed in high grade and advanced  stage tumors . There was an inverse 
correlation between ER, PR , Bcl-2 and Her 2 neu receptors expression in 
endometrial carcinomas included in the study.    
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